Circulating tumor cells: biology and clinical significance

D Lin, L Shen, M Luo, K Zhang, J Li, Q Yang… - Signal transduction and …, 2021 - nature.com
Circulating tumor cells (CTCs) are tumor cells that have sloughed off the primary tumor and
extravasate into and circulate in the blood. Understanding of the metastatic cascade of CTCs …

Targeted therapeutic options and future perspectives for HER2-positive breast cancer

J Wang, B Xu - Signal transduction and targeted therapy, 2019 - nature.com
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …

EMT: Mechanisms and therapeutic implications

M Singh, N Yelle, C Venugopal, SK Singh - Pharmacology & therapeutics, 2018 - Elsevier
Metastasis, the dissemination of cancer cells from primary tumors, represents a major hurdle
in the treatment of cancer. The epithelial-mesenchymal transition (EMT) has been studied in …

Circulating tumor cells: liquid biopsy of cancer

C Alix-Panabières, K Pantel - Clinical chemistry, 2013 - academic.oup.com
BACKGROUND The detection and molecular characterization of circulating tumor cells
(CTCs) are one of the most active areas of translational cancer research, with> 400 clinical …

Circulating tumor cells: approaches to isolation and characterization

M Yu, S Stott, M Toner, S Maheswaran… - Journal of Cell …, 2011 - rupress.org
Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with
blood components and are thus rare, making their isolation and characterization a major …

Circulating tumor cells: from new biological insights to clinical practice

X Gu, S Wei, X Lv - Signal Transduction and Targeted Therapy, 2024 - nature.com
The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …

Circulating tumour cells in cancer patients: challenges and perspectives

K Pantel, C Alix-Panabières - Trends in molecular medicine, 2010 - cell.com
Ultrasensitive methods have been recently developed to detect circulating tumour cells
(CTCs) in the peripheral blood and disseminated tumour cells (DTCs) in the bone marrow …

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

AJ Armstrong, MS Marengo, S Oltean, G Kemeny… - Molecular cancer …, 2011 - AACR
During cancer progression, malignant cells undergo epithelial-mesenchymal transitions
(EMT) and mesenchymal-epithelial transitions (MET) as part of a broad invasion and …

The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine

JS Ross, EA Slodkowska, WF Symmans… - The …, 2009 - academic.oup.com
Learning Objectives Contrast the current strengths and limitations of the three main slide-
based techniques (IHC, FISH, and CISH) currently in clinical use for testing breast cancer …

Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer

EC Dijkers, TH Oude Munnink… - Clinical …, 2010 - Wiley Online Library
We performed a feasibility study to determine the optimal dosage and time of administration
of the monoclonal antibody zirconium‐89 (89Zr)‐trastuzumab to enable positron emission …